Nir Giladi, MD
Chairman, Department of Neurology at Tel Aviv Sourasky Medical Center
Associate Professor of Neurology at Sackler School of Medicine, Tel-Aviv University
Location: Tel Aviv, Israel
Nir Giladi, MD, is a renowned leader in the field of movement disorders, an associate professor in the Sackler Faculty of Medicine at Tel Aviv University and chairman of the Department of Neurology at the Tel Aviv Sourasky Medical Center.
Prof. Giladi's research interests are in the field of gait, cognition and genetics in Parkinson's disease. In recent years Prof. Giladi, in collaboration with Prof. Orr-Urtreger, has developed and studied a unique cohort of over 900 PD patients from Ashkenazi Jewish origins, an ethnic group with unique genetic conserved substrate, using a whole genome approach as well as expression studies to identify markers in PD.
Prof. Giladi is a member of the International Parkinson and Movement Disorders Society (MDS) and is an officer (treasurer elect) since 2010. Prof. Giladi is also a member of the International Board of the Research Group of the World Health Organization on Parkinson's Disease and other Movement Disorders.
Prof. Giladi has nearly 200 papers published in peer reviewed journals and has served on the editorial boards of the Movement Disorders Journal, Parkinsonism & Related Disorders and the Journal of Neural Transmission (associate editor).
- Cortical and Subcortical Changes in Non-manifesting Carriers of the G2019S Mutation in the LRRK2 Gene (2013)
- Alpha-synuclein and Other Biomarkers in Biological Samples of LRRK2 Parkinsonís Disease (2013)
- fMRI of First Degree Relatives of LRRK2 Positive PD Patients (2011)
- Gait and Motor Symptoms in Healthy Asymptomatic Relatives of Patients with PD Who Are Carriers of Mutations in the LRRK2 Gene (2011)
- fMRI of first degree relatives of LRRK2 positive PD patients (2011)
- Clinical Assessment of Patients with PD Who Underwent DAT Scan and FDG PET at the Early Stages of Their Extra-Pyramidal Disorder as Part of Their Initial Workup (2010)
- Parkinson's Disease, Ashkenazi Jews and LRRK2: a consortium proposal (2009)